These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 11481234)

  • 1. Suppression of angiogenesis, tumor growth, and wound healing by resveratrol, a natural compound in red wine and grapes.
    Bråkenhielm E; Cao R; Cao Y
    FASEB J; 2001 Aug; 15(10):1798-800. PubMed ID: 11481234
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist.
    Kumar CC; Malkowski M; Yin Z; Tanghetti E; Yaremko B; Nechuta T; Varner J; Liu M; Smith EM; Neustadt B; Presta M; Armstrong L
    Cancer Res; 2001 Mar; 61(5):2232-8. PubMed ID: 11280792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of angiogenesis and angiogenesis-dependent tumor growth by the cryptic kringle fragments of human apolipoprotein(a).
    Kim JS; Chang JH; Yu HK; Ahn JH; Yum JS; Lee SK; Jung KH; Park DH; Yoon Y; Byun SM; Chung SI
    J Biol Chem; 2003 Aug; 278(31):29000-8. PubMed ID: 12746434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-angiogenic activity of the purine analog 6-thioguanine.
    Presta M; Belleri M; Vacca A; Ribatti D
    Leukemia; 2002 Aug; 16(8):1490-9. PubMed ID: 12145690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiangiogenic effects of latent antithrombin through perturbed cell-matrix interactions and apoptosis of endothelial cells.
    Larsson H; Sjöblom T; Dixelius J; Ostman A; Ylinenjärvi K; Björk I; Claesson-Welsh L
    Cancer Res; 2000 Dec; 60(23):6723-9. PubMed ID: 11118058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Jun N-terminal kinase activation is required for the inhibition of neovascularization by thrombospondin-1.
    Jiménez B; Volpert OV; Reiher F; Chang L; Muñoz A; Karin M; Bouck N
    Oncogene; 2001 Jun; 20(26):3443-8. PubMed ID: 11423995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor C induces angiogenesis in vivo.
    Cao Y; Linden P; Farnebo J; Cao R; Eriksson A; Kumar V; Qi JH; Claesson-Welsh L; Alitalo K
    Proc Natl Acad Sci U S A; 1998 Nov; 95(24):14389-94. PubMed ID: 9826710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p38 MAP kinase--a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability.
    Issbrücker K; Marti HH; Hippenstiel S; Springmann G; Voswinckel R; Gaumann A; Breier G; Drexler HC; Suttorp N; Clauss M
    FASEB J; 2003 Feb; 17(2):262-4. PubMed ID: 12490545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Domain swapping in a COOH-terminal fragment of platelet factor 4 generates potent angiogenesis inhibitors.
    Hagedorn M; Zilberberg L; Wilting J; Canron X; Carrabba G; Giussani C; Pluderi M; Bello L; Bikfalvi A
    Cancer Res; 2002 Dec; 62(23):6884-90. PubMed ID: 12460903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p38 MAP kinase negatively regulates endothelial cell survival, proliferation, and differentiation in FGF-2-stimulated angiogenesis.
    Matsumoto T; Turesson I; Book M; Gerwins P; Claesson-Welsh L
    J Cell Biol; 2002 Jan; 156(1):149-60. PubMed ID: 11781339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Goniodomin A, an antifungal polyether macrolide, exhibits antiangiogenic activities via inhibition of actin reorganization in endothelial cells.
    Abe M; Inoue D; Matsunaga K; Ohizumi Y; Ueda H; Asano T; Murakami M; Sato Y
    J Cell Physiol; 2002 Jan; 190(1):109-16. PubMed ID: 11807817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitor.
    Zilberberg L; Shinkaruk S; Lequin O; Rousseau B; Hagedorn M; Costa F; Caronzolo D; Balke M; Canron X; Convert O; Laïn G; Gionnet K; Goncalvès M; Bayle M; Bello L; Chassaing G; Deleris G; Bikfalvi A
    J Biol Chem; 2003 Sep; 278(37):35564-73. PubMed ID: 12837752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth factor-induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagen.
    Seandel M; Noack-Kunnmann K; Zhu D; Aimes RT; Quigley JP
    Blood; 2001 Apr; 97(8):2323-32. PubMed ID: 11290594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis and angiogenesis inhibition: an overview.
    Folkman J
    EXS; 1997; 79():1-8. PubMed ID: 9002217
    [No Abstract]   [Full Text] [Related]  

  • 15. FrzA, a secreted frizzled related protein, induced angiogenic response.
    Dufourcq P; Couffinhal T; Ezan J; Barandon L; Moreau C; Daret D; Duplàa C
    Circulation; 2002 Dec; 106(24):3097-103. PubMed ID: 12473558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Raf in vascular protection from distinct apoptotic stimuli.
    Alavi A; Hood JD; Frausto R; Stupack DG; Cheresh DA
    Science; 2003 Jul; 301(5629):94-6. PubMed ID: 12843393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration.
    Wood JM; Bold G; Buchdunger E; Cozens R; Ferrari S; Frei J; Hofmann F; Mestan J; Mett H; O'Reilly T; Persohn E; Rösel J; Schnell C; Stover D; Theuer A; Towbin H; Wenger F; Woods-Cook K; Menrad A; Siemeister G; Schirner M; Thierauch KH; Schneider MR; Drevs J; Martiny-Baron G; Totzke F
    Cancer Res; 2000 Apr; 60(8):2178-89. PubMed ID: 10786682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
    Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
    Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochalasin E, an epoxide containing Aspergillus-derived fungal metabolite, inhibits angiogenesis and tumor growth.
    Udagawa T; Yuan J; Panigrahy D; Chang YH; Shah J; D'Amato RJ
    J Pharmacol Exp Ther; 2000 Aug; 294(2):421-7. PubMed ID: 10900214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo effects of vascular endothelial growth factor on the chicken chorioallantoic membrane.
    Wilting J; Christ B; Bokeloh M; Weich HA
    Cell Tissue Res; 1993 Oct; 274(1):163-72. PubMed ID: 7694800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.